539 related articles for article (PubMed ID: 28832535)
1. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy.
Palmerston Mendes L; Pan J; Torchilin VP
Molecules; 2017 Aug; 22(9):. PubMed ID: 28832535
[TBL] [Abstract][Full Text] [Related]
2. Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.
Navath RS; Menjoge AR; Wang B; Romero R; Kannan S; Kannan RM
Biomacromolecules; 2010 Jun; 11(6):1544-63. PubMed ID: 20415504
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
[TBL] [Abstract][Full Text] [Related]
4. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
6. Dendrimer nanocarriers as versatile vectors in gene delivery.
Dutta T; Jain NK; McMillan NA; Parekh HS
Nanomedicine; 2010 Feb; 6(1):25-34. PubMed ID: 19450708
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in dendrimer-based nanocarriers.
Bai S; Thomas C; Rawat A; Ahsan F
Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
[TBL] [Abstract][Full Text] [Related]
8. Surface decorations of poly(amidoamine) dendrimer by various pendant moieties for improved delivery of nucleic acid materials.
Dehshahri A; Sadeghpour H
Colloids Surf B Biointerfaces; 2015 Aug; 132():85-102. PubMed ID: 26022400
[TBL] [Abstract][Full Text] [Related]
9. Novel 'Si-C' carbosilane dendrimers as carriers for anti-HIV nucleic acids: studies on complexation and interaction with blood cells.
Pedziwiatr-Werbicka E; Fuentes E; Dzmitruk V; Sánchez-Nieves J; Sudas M; Drozd E; Shakhbazau A; Shcharbin D; de la Mata FJ; Gomez-Ramirez R; Munoz-Fernandez MA; Bryszewska M
Colloids Surf B Biointerfaces; 2013 Sep; 109():183-9. PubMed ID: 23643914
[TBL] [Abstract][Full Text] [Related]
10. Modified Carboxyl-Terminated PAMAM Dendrimers as Great Cytocompatible Nano-Based Drug Delivery System.
Vu MT; Bach LG; Nguyen DC; Ho MN; Nguyen NH; Tran NQ; Nguyen DH; Nguyen CK; Hoang Thi TT
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022905
[TBL] [Abstract][Full Text] [Related]
11. Dendrimers as versatile platform in drug delivery applications.
Svenson S
Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
[TBL] [Abstract][Full Text] [Related]
12. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
Bugno J; Hsu HJ; Hong S
J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
[TBL] [Abstract][Full Text] [Related]
13. Dendronized Systems for the Delivery of Chemotherapeutics.
Dockery L; Daniel MC
Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
[TBL] [Abstract][Full Text] [Related]
14. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
15. The dendrimer paradox--high medical expectations but poor clinical translation.
Svenson S
Chem Soc Rev; 2015 Jun; 44(12):4131-44. PubMed ID: 25971933
[TBL] [Abstract][Full Text] [Related]
16. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).
Chang Y; Meng X; Zhao Y; Li K; Zhao B; Zhu M; Li Y; Chen X; Wang J
J Colloid Interface Sci; 2011 Nov; 363(1):403-9. PubMed ID: 21821262
[TBL] [Abstract][Full Text] [Related]
17. Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Parsian M; Mutlu P; Yalcin S; Tezcaner A; Gunduz U
Int J Pharm; 2016 Dec; 515(1-2):104-113. PubMed ID: 27725272
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.
Kesharwani P; Iyer AK
Drug Discov Today; 2015 May; 20(5):536-47. PubMed ID: 25555748
[TBL] [Abstract][Full Text] [Related]
19. Design of interior-functionalized fully acetylated dendrimers for anticancer drug delivery.
Hu J; Su Y; Zhang H; Xu T; Cheng Y
Biomaterials; 2011 Dec; 32(36):9950-9. PubMed ID: 21944725
[TBL] [Abstract][Full Text] [Related]
20. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
